Metabolites
Displaying metabolites 1326 - 1350 of 3755 in total
Metabolite ID | Name CAS Number | IUPAC Name | SMPDB Pathways | Weight Formula | Structure |
---|---|---|---|---|---|
ECMDB23261 | DG(14:0/14:0/0:0) | 2-hydroxy-3-(tetradecanoyloxy)propyl tetradecanoate | 512.8051 C31H60O5 | ||
ECMDB23278 | DG(16:0/12:0/0:0) | (2R)-3-(dodecanoyloxy)-2-hydroxypropyl hexadecanoate | phospholipid biosynthesis (PE(16:0/12:0(3-OH))) PW001744 | 512.816 C31H60O5 | |
ECMDB23295 | DG(18:0/10:0/0:0) | (2R)-3-(decanoyloxy)-2-hydroxypropyl octadecanoate | phospholipid biosynthesis (CDP-DG(18:0/10:0)) PW001761 | 512.816 C31H60O5 | |
ECMDB23247 | DG(10:0/18:0/0:0) | (2S)-3-(decanoyloxy)-2-hydroxypropyl octadecanoate | 512.816 C31H60O5 | ||
ECMDB23254 | DG(12:0/16:0/0:0) | (2S)-3-(dodecanoyloxy)-2-hydroxypropyl hexadecanoate | 512.816 C31H60O5 | ||
ECMDB06823 | 2,5-Diamino-6-(5'-triphosphoryl-3',4'-trihydroxy-2'-oxopentyl)-amino-4-oxopyrimidine | [({[({5-[(2,5-diamino-6-oxo-3,6-dihydropyrimidin-4-yl)amino]-2,3-dihydroxy-4-oxopentyl}oxy)(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl)oxy]phosphonic acid | Folate biosynthesis PW000908 | 513.1856 C9H18N5O14P3 | |
ECMDB20059 | 2,5-Diaminopyrimidine nucleoside triphosphate | ({[({[(2R,3S,4R,5R)-5-[(2,5-diamino-6-oxo-1,6-dihydropyrimidin-4-yl)amino]-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid | Folate biosynthesis PW000908 | 513.1856 C9H18N5O14P3 | |
ECMDB24756 | DG(12:0(3-OH)/15:0/0:0) | (2R)-2-hydroxy-3-[(3-hydroxydodecanoyl)oxy]propyl pentadecanoate | phospholipid biosynthesis (CL(12:0(3-OH)/15:0/12:0(3-OH)/15:0)) PW001920 | 514.788 C30H58O6 | |
ECMDB24781 | DG(15:0/12:0(3-OH)/0:0) | (2S)-2-hydroxy-3-[(3-hydroxydodecanoyl)oxy]propyl pentadecanoate | phospholipid biosynthesis (CL(15:0/12:0(3-OH)/15:0/12:0(3-OH))) PW001946 | 514.788 C30H58O6 | |
ECMDB24016 | Taurocholic acid | 2-[(4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanamido]ethane-1-sulfonic acid | 515.703 C26H45NO7S | ||
ECMDB24754 | DG(12:0(3-OH)/14:0(3-OH)/0:0) | (2S)-2-hydroxy-3-[(3-hydroxydodecanoyl)oxy]propyl 3-hydroxytetradecanoate | phospholipid biosynthesis (CL(12:0(3-OH)/14:0(3-OH)/12:0(3-OH)/14:0(3-OH))) PW001918 | 516.76 C29H56O7 | |
ECMDB24767 | DG(14:0(3-OH)/12:0(3-OH)/0:0) | (2R)-2-hydroxy-3-[(3-hydroxydodecanoyl)oxy]propyl 3-hydroxytetradecanoate | phospholipid biosynthesis (CL(14:0(3-OH)/12:0(3-OH)/14:0(3-OH)/12:0(3-OH))) PW001934 | 516.76 C29H56O7 | |
ECMDB20246 | 8-Hydroxydeoxyguanosine 5'-triphosphate | 9-[4-hydroxy-5-({[hydroxy({[hydroxy(phosphonatooxy)phosphoryl]oxy})phosphoryl]oxy}methyl)oxolan-2-yl]-2-imino-3,9-dihydro-2H-purine-6,8-bis(olate) | 519.1487 C10H12N5O14P3 | ||
ECMDB20083 | 4-(Cytidine 5'-diphospho)-2-C-methyl-D-erythritol | [({[(2R,3S,4R,5R)-3,4-dihydroxy-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy][(2R,3S)-2,3,4-trihydroxy-3-methylbutoxy]phosphinic acid | 519.294 C14H23N3O14P2 | ||
ECMDB02206 | Molybdopterin 73508-07-3 | molybdenum(2+) ion 8-[(hydrogen phosphonooxy)methyl]-2-imino-6,7-disulfanyl-1H,2H,5H,5aH,8H,9aH,10H-pyrano[3,2-g]pteridin-4-olate dihydrate | 521.27 C10H12MoN5O8PS2 | ||
ECMDB23734 | Ubiquinone-5 | 2,3-dimethoxy-5-methyl-6-[(2E,6E,10E,14E)-3,7,11,15,19-pentamethylicosa-2,6,10,14,18-pentaen-1-yl]cyclohexa-2,5-diene-1,4-dione | TCA cycle (ubiquinol-5) PW001005 | 522.7584 C34H50O4 | |
ECMDB01273 | Guanosine triphosphate 86-01-1 | ({[({[(2R,3S,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid | Pyrimidine metabolism PW000942 Folate biosynthesis PW000908 Amino sugar and nucleotide sugar metabolism II PW000887 Aspartate metabolism PW000787 More...GTP degradation PW001888 Mannose Metabolism PW000822 adenosylcobalamin salvage from cobinamide PW001884 colanic acid building blocks biosynthesis PW000951 preQ0 metabolism PW001893 purine nucleotides de novo biosynthesis PW000910 purine nucleotides de novo biosynthesis 1435709748 PW000960 Flavin biosynthesis PW001971 guanylyl molybdenum cofactor biosynthesis PW002032 purine nucleotides de novo biosynthesis 2 PW002033 Tetrahydromonapterin Biosynthesis PW002043 | 523.1804 C10H16N5O14P3 | |
ECMDB20324 | ppGp 58902-76-4 | {[(2R,3S,4R,5R)-4-hydroxy-2-({[hydroxy(phosphonooxy)phosphoryl]oxy}methyl)-5-(6-hydroxy-2-imino-3,9-dihydro-2H-purin-9-yl)oxolan-3-yl]oxy}phosphonic acid | 523.1804 C10H16N5O14P3 | ||
ECMDB23233 | 8-oxo-dGTP 139307-94-1 | ({[({[(2R,3S,5R)-5-(2-amino-6,8-dioxo-6,7,8,9-tetrahydro-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid | 523.1804 C10H16N5O14P3 | ||
ECMDB23729 | Guanosine-3'-diphosphate 5'-phosphate | {[hydroxy({[(2R,3S,4R,5R)-4-hydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2H-purin-9-yl)-2-[(phosphonooxy)methyl]oxolan-3-yl]oxy})phosphoryl]oxy}phosphonic acid | 523.1804 C10H16N5O14P3 | ||
ECMDB21588 | PE(10:0/10:0) | (2-aminoethoxy)[(2R)-2,3-bis(decanoyloxy)propoxy]phosphinic acid | 523.6402 C25H50NO8P | ||
ECMDB00293 | Xanthosine 5-triphosphate 6253-56-1 | ({[({[(2R,3S,4R,5R)-5-(2,6-dihydroxy-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid | Collection of Reactions without pathways PW001891 | 524.1652 C10H15N4O15P3 | |
ECMDB21572 | Succinate-semialdehyde-thiamine PPi | 5-[2-({[(3-carboxylato-1-hydroxypropyl phosphonato)oxy]phosphinato}oxy)ethyl]-3-[(6-imino-2-methyl-1,6-dihydropyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium | 524.379 C16H22N4O10P2S | ||
ECMDB21578 | Ubiquinol-5 | 2,3-dimethoxy-5-methyl-6-[(2E,6E,10E,14E)-3,7,11,15,19-pentamethylicosa-2,6,10,14,18-pentaen-1-yl]benzene-1,4-diol | TCA cycle (ubiquinol-5) PW001005 | 524.7743 C34H52O4 | |
ECMDB24765 | DG(12:0/17:0cycw7c/0:0) | (2S)-3-{[8-(2-hexylcyclopropyl)octanoyl]oxy}-2-hydroxypropyl dodecanoate | phospholipid biosynthesis (CL(12:0/17:0cycw7c/12:0/12:0)) PW001932 | 524.827 C32H60O5 |